Mechanisms of disease: Major depressive disorder

被引:0
|
作者
Belmaker, R. H. [1 ]
Agam, Galila [1 ]
机构
[1] Ben Gurion Univ Negev, Beer Sheva, Israel
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 358卷 / 01期
基金
英国医学研究理事会;
关键词
D O I
10.1056/NEJMra073096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It would be appealing to attempt to categorize depression in terms of monoamine-depletion forms that are perhaps related to genes coding for enzymes involved in neurotransmission and cortisolrelated forms that are characterized by a more long-term course, hippocampal atrophy, and a history of psychosocial stress. However, the clinical data do not fall into such neat categories, since monoamine-based antidepressants are most effective in patients with severe depression when cortisol levels remain high after the administration of dexamethasone. Major depressive disorder is likely to have a number of causes. Middle-aged or elderly patients presenting with depression may have a disorder related to cardiovascular disease and originating from endothelial dysfunction.128 Patients in their late teens or early 20s who have severe depression may have important genetic risk factors and a high risk of manic episodes.8 In patients with an anxious and depressive personality, depression may be due to genetically determined personality factors11 or adverse childhood experiences.129 Avoidance of premature closure on any one scientific theory of the mechanism of depression will best serve the search for new, more effective treatments. It is likely that the pathogenesis of acute depression is different from that of recurrent or chronic depression, which is characterized by long-term declines in function and cognition. Mood can be elevated (by stimulants,46 by brain stimulation,123 or by ketamine94) or depressed (by monoamine depletion19 in recovered patients) for short periods, but longer-term improvement may require reduction of the abnormal glucocorticoid function induced by stress or increases in brain neurotrophic factors. Copyright © 2008 Massachusetts Medical Society.
引用
收藏
页码:55 / 68
页数:14
相关论文
共 50 条
  • [21] Progress and challenges in research of the mechanisms of anhedonia in major depressive disorder
    Su, Yun-Ai
    Si, Tianmei
    GENERAL PSYCHIATRY, 2022, 35 (01)
  • [22] Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review
    Damien Prouzeau
    Ismaël Conejero
    Peter L. Voyvodic
    Carine Becamel
    Mocrane Abbar
    Jorge Lopez-Castroman
    Current Psychiatry Reports, 2022, 24 : 573 - 581
  • [23] Defense Mechanisms and Major Depressive Disorder in African American Women
    Porcerelli, John H.
    Olson, Trevor R.
    Presniak, Michelle D.
    Markova, Tsveti
    Miller, Kristen
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2009, 197 (10) : 736 - 741
  • [24] Neurobiological Mechanisms Associated with Treatment Response in Major Depressive Disorder
    Drevets, Wayne C.
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 11S - 11S
  • [25] MAJOR DEPRESSIVE DISORDER IN CORONARY-ARTERY DISEASE
    CARNEY, RM
    RICH, MW
    TEVELDE, A
    SAINI, J
    CLARK, K
    JAFFE, AS
    AMERICAN JOURNAL OF CARDIOLOGY, 1987, 60 (16): : 1273 - 1275
  • [26] Major depressive disorder
    Long, Thomas C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (17): : 1869 - 1869
  • [27] MAJOR DEPRESSIVE DISORDER
    SPANER, D
    BLAND, RC
    NEWMAN, SC
    ACTA PSYCHIATRICA SCANDINAVICA, 1994, 89 : 7 - 15
  • [28] Major depressive disorder
    Grobler, G.
    SOUTH AFRICAN JOURNAL OF PSYCHIATRY, 2013, 19 (03) : 157 - 163
  • [29] Major Depressive Disorder
    Odubiyi, Fausat Funmi
    ANNALS OF CLINICAL PSYCHIATRY, 2023, 35 (03) : 4 - 4
  • [30] Major depressive disorder
    Otte, Christian
    Gold, Stefan M.
    Penninx, Brenda W.
    Pariante, Carmine M.
    Etkin, Amit
    Fava, Maurizio
    Mohr, David C.
    Schatzberg, Alan F.
    NATURE REVIEWS DISEASE PRIMERS, 2016, 2